FibroGen Alpha and Beta Analysis
| FGENDelisted Stock | USD 9.71 0.69 7.65% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as FibroGen. It also helps investors analyze the systematic and unsystematic risks associated with investing in FibroGen over a specified time horizon. Remember, high FibroGen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to FibroGen's market risk premium analysis include:
Beta (0.14) | Alpha (0.12) | Risk 4.14 | Sharpe Ratio (0.03) | Expected Return (0.12) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
FibroGen |
FibroGen Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. FibroGen market risk premium is the additional return an investor will receive from holding FibroGen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FibroGen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate FibroGen's performance over market.| α | -0.12 | β | -0.14 |
FibroGen expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of FibroGen's Buy-and-hold return. Our buy-and-hold chart shows how FibroGen performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.FibroGen Market Price Analysis
Market price analysis indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By understating and applying FibroGen stock market price indicators, traders can identify FibroGen position entry and exit signals to maximize returns.
FibroGen Return and Market Media
The median price of FibroGen for the period between Sun, Oct 12, 2025 and Sat, Jan 10, 2026 is 8.93 with a coefficient of variation of 11.79. The daily time series for the period is distributed with a sample standard deviation of 1.12, arithmetic mean of 9.53, and mean deviation of 1.03. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About FibroGen Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including FibroGen or other delisted stocks. Alpha measures the amount that position in FibroGen has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
FibroGen Upcoming Company Events
As portrayed in its financial statements, the presentation of FibroGen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, FibroGen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of FibroGen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of FibroGen. Please utilize our Beneish M Score to check the likelihood of FibroGen's management manipulating its earnings.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with FibroGen
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out FibroGen Backtesting, FibroGen Valuation, FibroGen Correlation, FibroGen Hype Analysis, FibroGen Volatility, FibroGen History and analyze FibroGen Performance. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in FibroGen Stock
If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |